More about

Stephenson Cancer Center At The University Of Oklahoma

News
May 30, 2025
2 min read
Save

At-home intervention has potential to enhance cancer care delivery, outcomes

CHICAGO — An intervention designed to provide supportive oncology care at home may enhance care delivery and improve outcomes for people receiving curative cancer treatment, according to findings presented at ASCO Annual Meeting.

News
October 30, 2024
5 min read
Save

Strategies can make adjustment to daylight saving time easier, mitigate health impacts

Daylight saving time has been a source of contention and debate since its introduction in 1918.

News
October 10, 2024
3 min read
Save

Novel drug delivery approach may protect against cisplatin-related hearing loss

A novel drug delivery construct may protect individuals against cisplatin-induced ototoxicity and associated hearing loss.

News
June 26, 2023
10 min read
Save

Oncologists play key role in diagnosing immune checkpoint inhibitor-induced myocarditis

Incidence of immune checkpoint inhibitor-induced myocarditis may increase as more patients receive immunotherapy. In this special report, Healio | HemOnc Today highlights how a multidisciplinary approach can reduce mortality through early recognition and prompt intervention.

News
June 12, 2023
2 min read
Save

Mirvetuximab soravtansine data ‘practice changing’ for subset of women with ovarian cancer

CHICAGO — Mirvetuximab soravtansine-gynx extended survival of women with platinum-resistant ovarian cancer and high folate receptor-alpha expression, according to a study that compared the agent with investigator’s choice of chemotherapy.

News
June 02, 2023
3 min read
Save

Simple hysterectomy safe for early-stage, low-risk cervical cancer

CHICAGO — Pelvic node dissection and simple hysterectomy appeared noninferior to radical hysterectomy at 3 years among women with early-stage, low-risk cervical cancer, according to data from the SHAPE study.

News
June 06, 2022
3 min read
Save

Timely intervention critical for major cardiac events after immune checkpoint therapy

CHICAGO — Patients and prescribers should be more aware of the potential for major adverse cardiac events after immune checkpoint inhibitor-based therapy, according to retrospective study results presented at ASCO Annual Meeting.